<DOC>
	<DOCNO>NCT02696564</DOCNO>
	<brief_summary>A randomize , parallel , placebo control trial evaluate effect 100mg/day losartan progression emphysema measure quantitative HRCT compare placebo</brief_summary>
	<brief_title>Losartan Effects Emphysema Progression</brief_title>
	<detailed_description>This pragmatic trial design test treatment , losartan , may decrease progression Chronic Obstructive Pulmonary Disease ( COPD ) . Losartan angiotensin receptor block agent , commonly use antihypertensive agent , show alter cardiac remodel myocardial infarction renovascular remodel diabetes-mellitus . In trial participant mild severe COPD , Computed Tomography ( CT ) evidence emphysema ( 5-35 % voxels &lt; -950 Hounsfield Units ) , randomly assign receive 100mg/day losartan placebo 48 week . The primary outcome measure rate progression emphysema , quantify percent lung voxels density less -950 HU measure High Resolution CT ( HRCT , baseline 48 week .</detailed_description>
	<mesh_term>Emphysema</mesh_term>
	<mesh_term>Pulmonary Emphysema</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<criteria>Mild severe COPD : Ratio force expiratory volume 1 second ( FEV1 ) /forced vital capacity ( FVC ) less equal 0.70 , FEV1 3070 % predict Current former smoker HRCT scan 535 % voxels density le 950 Hounsfield Units ( HU ) Ability understand willingness sign consent document Current therapy angiotensin convert enzyme ( ACE ) inhibitor angiotensin receptor blocker ( ARB ) Known intolerance ACE inhibitor ARB History angioedema Conventional indication ACE inhibitor ARB ( e.g. , history myocardial infarction , know cardiomyopathy ) Renal insufficiency ( GFR &lt; 30 mL/min CockcroftGault calculation ) Current regular use NSAIDs define daily use 5 day week one month Potassium supplementation serum potassium level 5.0 milliequivalent ( mEq ) /dL high V1 Current use potassium spar diuretic COPD exacerbation require treatment within 6 week V1 Chronic systemic corticosteroid use 10mg/day prednisone Chronic oxygen use 2 L/min nasal cannula rest clinical evidence cor pulmonale Untreated arterial hypertension ( systolic blood pressure great than140 mm Hg , diastolic blood pressure great 90 mm Hg ) Blood pressure le 90 mm Hg systolic 60 mm Hg diastolic stand sit Known unilateral bilateral renal artery stenosis high 70 % Previous lung resection surgery Evidence interstitial , occupational chronic infectious lung disease Changes chest preclude adequate HRCT imaging ( e.g . Metallic object chest shrapnel pacemaker lead ) For woman child bear potential , positive pregnancy test unwillingness use two method birth control abstinence duration study Major chronic illness judgment study physician would interfere participation study e.g . include limited : cardiac , renal , hepatic ( LFTs 2.5x normal upper limit ) , neurological , psychiatric , endocrine neoplastic disease , uncontrolled diabetes , uncontrolled HIV infection immune system disorder , hyperthyroidism , seizure disorder , nonskin cancer , rheumatic disease Failure keep screening appointment indicator nonadherence Inability contact telephone Intention leave area within 12 month</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>COPD</keyword>
	<keyword>emphysema</keyword>
	<keyword>HRCT</keyword>
	<keyword>losartan</keyword>
</DOC>